medigraphic.com
Colegio de Medicina Interna de México.

2022, Number 2

<< Back Next >>

Med Int Mex 2022; 38 (2)

Abdominal circumference and waistheight ratio as obesity criteria in metabolic syndrome

Corona-Meléndez JC, Torres-Made LM, Bañuelos-Contreras EJ, Flores-Montes JR, Medina-Ruiz E

Language: Spanish
References: 41
Page: 235-247
PDF size: 479.40 Kb.


ABSTRACT

Objective: To determine if it is possible to use the waist-height ratio (WhR) instead of abdominal circumference as criterion of metabolic syndrome.
Materials and Methods: A cross-sectional, observational, analytical and comparative, diagnostic-test study, done from March 2014 to February 2015 in participants over 18 years of age, both sexes. IDF/NHLBI/AHA/WHF/IAS/IASO 2009 metabolic syndrome definition was used, and WhR was calculated, previous informed consent. We calculated sensibility, specificity, predictive values, and likelihood ratios for metabolic syndrome and for each criterion, as well as Pearson correlation.
Results: There were included 413 participants, from which 322 (78%) were men. Overall median age was 44 years. Pearson correlation for abdominal circumference and WhR was 0.917 (p ‹ 0.0001, increasing to 0.935 adjusted for age, sex and comorbidities). Metabolic syndrome prevalence using abdominal circumference was 35.6%, and 37% using WhR. Superiority for WhR as compared with abdominal circumference as criterion for metabolic syndrome was observed in sensitivity (100% vs 97.9%), positive defipredictive value (42.3% vs 41.6%), negative predictive value (100% vs 95.5%), positive likelihood ratio (5.37 vs 4.25) and negative likelihood ratio (0.0 vs 0.09).
Conclusions: Waist-height ratio could be used as a better surrogate of intraabdominal obesity instead of abdominal circumference in the definition of the metabolic syndrome.


REFERENCES

  1. Reaven GM. Role of insulin resistance in human disease (syndrome X): an expanded definition. Diabetes 1988; 37: 1595-607. doi: 10.1146/annurev.me.44.020193.001005.

  2. Isomaa B, Almgren P, Tuomi T, Forsen B, et al. Cardiovascular morbidity and mortality associated with metabolic syndrome. Diabetes Care 2001; 24: 683-9. doi: 10.2337/ diacare.24.4.683.

  3. Klein BEK, Klein R, Lee KE. Components of the metabolic syndrome and risk of cardiovascular disease and diabetes in Beaver Dam. Diabetes Care 2002; 25: 1790-4. doi: 10.2337/ diacare.25.10.1790.

  4. Alexander CM, Landsman PB, Teutsch SM, Haffner SM. NCEP-defined metabolic syndrome, diabetes and prevalence of coronary heart disease among NHANES III participants age 50 years and older. Diabetes Care 2003; 52: 1210-4. doi: 10.2337/diabetes.52.5.1210.

  5. McNeill AM, Rosamond WD, Girman CJ, Golden SH, et al. The metabolic syndrome and 11 year risk of incident cardiovascular disease in the Atherosclerosis Risk Communities (ARIC) Study. Diabetes Care 2005; 28: 385-90. doi: 10.2337/diacare.28.2.385.

  6. Lorenzo C, Hunt KJ, Williams K, Haffner SM. Trend in the prevalence of the metabolic syndrome and its impact on cardiovascular disease incidence. Diabetes Care 2006; 29: 625-30. doi: 10.2337/diacare.29.03.06.dc05-1755.

  7. World Health Organization. Definition, diagnosis and classification of diabetes mellitus and its complications: report of WHO consultation. Part 1: diagnosis and classification of diabetes mellitus. Geneva, Switzerland: World Health Organization; 1999. Disponible en: https://apps.who.int/ iris/bitstream/handle/10665/66040/WHO_NCD_NCS_99 .2.pdf;jsessionid=A44498158297612B7181DFE12BE38E2 0?sequence=1 (última visita 10/08/2020).

  8. Balkau B, Charles MA, the European Group for the Study of Insulin Resistance (EGIR): Comment on the provisional report from the WHO consultation. Diabet Med 1999; 16: 442-3. doi: 10.1046/j.1464-5491.1999.00059.x.

  9. Third Report of the National Cholesterol Education Program (NCEP), Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). National Institute of Health, 2001. Disponible en: https://www.nhlbi.nih.gov/files/docs/guidelines/ atp3xsum.pdf (última visita 10/08/2020).

  10. Executive summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adult (Adult Treatment Panel III). JAMA 2001; 285: 2486-97. doi: 10.1001/jama.285.19.2486.

  11. Grundy SM, Cleeman JI, Merz CNB, Brewer HB, et al. Implications of recent trials for the National Cholesterol Education Program Adult Treatment Panel III Guidelines: NCEP report. Circulation 2004; 110: 227-39. https://doi. org/10.1161/01.CIR.0000133317.49796.0E.

  12. Einhorn D, Reaven G, Cobin R, Ford E, et al. American College of Endocrinology position statement on the insulin resistance syndrome. Endocr Pract 2003; 9: 237-52.

  13. IDF consensus worldwide definition of the metabolic syndrome. International Diabetes Federation, April 2005. Disponible en: https://www.idf.org/e-library/consensusstatements/ 60-idfconsensus-worldwide-definitionof-themetabolic- syndrome.html (última visita 10/08/2020).

  14. Grundy SM, Brewer HBJ, Cleeman JI, Smith SC, et al. Definition of metabolic syndrome. Report of the National Heart, Lung and Blood Institute/American Heart Association conference on scientific issues related to definition. Arterioscler Thromb Vasc Biol 2004; 24 (2): e13-8. doi: 10.1161/01.ATV.0000111245.75752.C6.

  15. Alberti KGMM, Eckel RH, Grundy SM, Zimmet PZ, et al. Harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity. Circulation 2009; 120: 1640-5. doi: 10.1161/ CIRCULATIONAHA.109.192644.

  16. Nilsson G, Hedberg P, Jonason T, Lönnberg I, et al. Waist circumference alone predicts insulin resistance as good as the metabolic syndrome in elderly women. EJIM 2008; 19: 520-6. https://doi.org/10.1016/j.ejim.2008.01.018.

  17. Patel PV, Gilski D, Morrison J. Using waist circumference to screen for metabolic syndrome in an inpatient population. Crit Pathw Cardiol 2010; 9: 152-5. doi: 10.1097/ HPC.0b013e3181f005a5.

  18. Ashwell M, Cole TJ, Dixon AK. Obesity: new insight into the anthropometric classification of fat distribution shown by computed tomography. BMJ 1985; 290: 1692-4. doi: 10.1136/bmj.290.6483.1692.

  19. Seidell JC, Cigolini M, Charzewska J, Ellsinger BT, et al. Fat distribution in European women: a comparison of anthropometric measurements in relation to cardiovascular risk factors. Int J Epidemiol 1990; 19: 303-8. oi: 10.1093/ ije/19.2.303.

  20. Bjorntorp P. The associations between obesity, adipose tissue distribution and disease. Acta Med Scand 1988; 723: 121-34. doi: 10.1111/j.0954-6820.1987.tb05935.x.

  21. Han TS, van Leer EM, Seidell JC, Lean ME. Waist circumference action levels in the identification of cardiovascular risk factors: prevalence study in a random sample. BMJ 1995; 311: 1401-5. doi: 10.1136/bmj.311.7017.1401.

  22. Ashwell M, Lejeune S, McPherson K. Ratio of waist circumference to height may be better indicator of need for weight management. BMJ 1996; 312: 377. doi: 10.1136/ bmj.312.7027.377.

  23. Ashwell M, Cole TJ, Dixon AK. Ratio of waist circumference to height is strong predictor of intraabdominal fat. BMJ 1996; 313: 559-60. doi: 10.1136/bmj.313.7056.559d.

  24. Ashwell M, Hsieh SD. Six reasons why the waist-to-height ratio is a rapid and effective global indicator for health risks of obesity and how its use could simplify the international public health message on obesity. Int J Food Sci Nutr 2005; 56: 303-7. doi: 10.1080/09637480500195066.

  25. Browning LM, Hsieh SD, Ashwell M. A systematic review of waist to height ratio as a screening tool for the prediction of cardiovascular disease and diabetes: 0.5 could be a suitable global boundary value. Nutr Res Rev 2010; 23: 247-69. doi: 10.1017/S0954422410000144.

  26. Ashwell M, Gunn P, Gibson S. Waist-to-height ratio is a better screening tool than waist circumference and BMI for adult cardiometabolic risk factors: a systematic review and meta-analysis. Obes Rev 2012; 13: 275-86. doi: 10.1111/j.1467-789X.2011.00952.x.

  27. Velasco-Rodríguez V, Martínez-Ordaz V, Roiz-Hernández J, Huazano-García F, et al. Muestreo y tamaño de muestra. 1ª ed. Torreon, Coahuila, México: Víctor Manuel Velasco Rodríguez, 2002;89-90.

  28. Principios éticos para las investigaciones médicas en seres humanos. Declaración de Helsinki. Disponible en: http:// www.fisterra.com/mbe/investiga/declaracion_helsinki.asp (última visita: 10/08/2020).

  29. Reglamento de la Ley General de Salud en Materia de Investigación para la Salud. Secretaría de Salud. Disponible en: http://www.salud.gob.mx/unidades/cdi/nom/compi/ rlgsmis.html. (última visita: 10/08/2020).

  30. Lerman-Garber I, Aguilar-Salinas AC, Gómez-Pérez FJ, Reza-Albarán A, et al. El síndrome metabólico: Posición de la Sociedad Mexicana de Nutrición y Endocrinología sobre la definición, fisiopatología y diagnóstico; características del síndrome metabólico en México. Rev Endocrinol Nutr 2004; 12: 109-22.

  31. Aguilar-Salinas CA, Rojas R, Gómez-Pérez FJ, Valles V, et al. High prevalence of metabolic syndrome in México. Arch Med Res 2004; 35: 76-81. doi: 10.1016/j.arcmed. 2003.06.006.

  32. Quiroga-Juárez GL, Cantú-Martínez PC. La prevalencia del síndrome metabólico en personal de altos mandos de un grupo de empresas regiomontanas. RESPYN 2007; 8.

  33. Martínez LE, Flores BA, Alonso CM. Prevalencia del síndrome metabólico en población militar que acude a valoración médica anual. Rev Sanid Milit Mex 2007; 61: 361-6.

  34. Suárez O, Gutiérrez B. Prevalencia de hipertensión y síndrome metabólico en una muestra de población mexicana. Med Int Mex 2006; 22: 183-8.

  35. Córdoba JA, Barquera S, Campos I, et al. Análisis de conglomerados de factores de riesgo para enfermedades crónicas en adultos mexicanos. Draft 2007.

  36. Echavarría-Pinto M, Hernández-Lomelí A, Alcocer-Gamba MA, Morales-Flores H, et al. Síndrome metabólico en adultos de 20 a 40 años en una comunidad rural mexicana. Rev Med Inst Mex Seguro Soc 2006; 44: 329-35.

  37. Velásquez-Monroy O, Rosas-Peralta M, Lara-Esqueda A, Pastelín-Hernandez G, et al. Prevalencia e interrelación de enfermedades crónicas no transmisibles y factores de riesgo cardiovascular en México: Resultados finales de la Encuesta Nacional de Salud (ENSA) 2000. Arch Cardiol Mex 2003; 73: 62-77.

  38. Instituto Nacional de Salud Pública. Diabetes mellitus. Tomo 2. La salud de los adultos. Encuesta Nacional de Salud (ENSA, 2000). México: Instituto Nacional de Salud Pública, Secretaría de Salud; 2001.

  39. Olaiz-Fernández G, Rivera-Dommarco J, Shamah-Levy T, Rojas R, et al. Encuesta Nacional de Salud y Nutrición 2006. Cuernavaca, Morelos, México: Instituto Nacional de Salud Pública; 2006.

  40. Wacher-Rodarte N. Epidemiología del síndrome metabólico. Gac Med Mex 2009; 145 (5): 384-391.

  41. Barquera S, Campos-Nonato I, Hernández-Barrera L, Pedroza-Tobías A, et al. Prevalencia de obesidad en adultos mexicanos, ENSANUT 2012. Salud Pública Mex 2013; 55 (Suppl2): S151-S160.




2020     |     www.medigraphic.com